Mirae Asset Global Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.1K Buy
+672
New +$19.1K ﹤0.01% 1488
2026
Q1
Sell
-702
Closed -$23K 1645
2025
Q4
$23K Buy
702
+148
+27% +$4.78K ﹤0.01% 1521
2025
Q3
$19.2K Sell
554
-18
-3% -$576 ﹤0.01% 1500
2025
Q2
$16K Buy
572
+83
+17% +$2.23K ﹤0.01% 1426
2025
Q1
$12.4K Buy
489
+24
+5% +$606 ﹤0.01% 1449
2024
Q4
$12.7K Sell
465
-268
-37% -$7.47K ﹤0.01% 1485
2024
Q3
$21.5K Buy
733
+126
+21% +$3.43K ﹤0.01% 1424
2024
Q2
$15.3K Buy
+607
New +$17.2K ﹤0.01% 1421

Other funds holding LKFT

Mirae Asset Global Investments's LKFT Position: Q2 2026 in Review

Mirae Asset Global Investments opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026: 672 shares worth $20.1K. The stake represents ﹤0.01% of the portfolio and ranks #1488 among its holdings. This is a return to the name: Mirae Asset Global Investments previously reported a position in LKFT as recently as Q4 2025.

Mirae Asset Global Investments first reported a position in LKFT in Q2 2024 and has held it in 8 quarters since. The position peaked at $23K in Q4 2025. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Mirae Asset Global Investments held 672 shares of Lakefront Biotherapeutics American Depositary Shares worth $20.1K as of Q2 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new Mirae Asset Global Investments position in Q2 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1488 holding.
  • Mirae Asset Global Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $23K in Q4 2025.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.